EBR Systems, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBRCZ research report →
Companyebrsystemsinc.com
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart.
- CEO
- John Graham McCutcheon
- IPO
- 2023
- Employees
- 89
- HQ
- Sunnyvale, CA, US
Price Chart
Valuation
- Market Cap
- $277.38M
- P/E
- -30.20
- P/S
- 42.09
- P/B
- 174.33
- EV/EBITDA
- -4.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 17.00%
- Op Margin
- -1322.69%
- Net Margin
- -1393.29%
- ROE
- -179.23%
- ROIC
- -75.41%
Growth & Income
- Revenue
- $1.62M · 0.00%
- Net Income
- $-48,758,000 · -141.68%
- EPS
- $-0.12 · 0.00%
- Op Income
- $-47,690,606
- FCF YoY
- -37.04%
Performance & Tape
- 52W High
- $1.50
- 52W Low
- $0.37
- 50D MA
- $0.48
- 200D MA
- $0.65
- Beta
- 0.18
- Avg Volume
- 2.47K
Get TickerSpark's AI analysis on EBRCZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EBRCZ Coverage
We haven't published any research on EBRCZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EBRCZ Report →